PERGOLIDE, A POTENT LONG-ACTING DOPAMINE-RECEPTOR AGONIST

被引：62
|
作者：
LEMBERGER, L
CRABTREE, R
CALLAGHAN, JT
机构：
[1] INDIANA UNIV,SCH MED,DEPT PHARMACOL,INDIANAPOLIS,IN 46204
[2] INDIANA UNIV,SCH MED,DEPT MED,INDIANAPOLIS,IN 46204
[3] INDIANA UNIV,SCH MED,DEPT PSYCHIAT,INDIANAPOLIS,IN 46204
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 1980年 / 27卷 / 05期
关键词：
D O I：
10.1038/clpt.1980.91
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：642 / 651
页数：10
相关论文
共 50 条
  • [21] ADTN - A POTENT DOPAMINE RECEPTOR AGONIST
    WOODRUFF, GN
    TRENDS IN PHARMACOLOGICAL SCIENCES, 1982, 3 (02) : 59 - 61
  • [22] Expression and Characterization of a Potent Long-Acting GLP-1 Receptor Like Agonist, Exendin-4-Fc
    Zhang, Wen
    Li, Ming
    Zan, Yanlu
    Bai, Yi
    INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS, 2021, 27 (04) : 2517 - 2526
  • [23] Expression and Characterization of a Potent Long-Acting GLP-1 Receptor Like Agonist, Exendin-4-Fc
    Wen Zhang
    Ming Li
    Yanlu Zan
    Yi Bai
    International Journal of Peptide Research and Therapeutics, 2021, 27 : 2517 - 2526
  • [24] The in vitro pharmacological profile of LAS100977-a potent, selective and long-acting beta-2 receptor agonist
    Aparici, M.
    Gomez-Angelats, M.
    Vilella, D.
    Cortijo, J.
    Morcillo, E. J.
    Carcasona, C.
    Gavalda, A.
    Beleta, J.
    Puig, C.
    Ryder, H.
    Miralpeix, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [25] Engineering a Potent, Long-Acting, and Periphery-Restricted Oxytocin Receptor Agonist with Anorexigenic and Body Weight Reducing Effects
    Pflimlin, Elsa
    Zhou, Zhihong
    Amso, Zaid
    Fu, Qiangwei
    Lee, Candy
    Muppiddi, Avinash
    Joseph, Sean B.
    Van Nguyen-Tran
    Shen, Weijun
    JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (01) : 382 - 390
  • [26] Effectiveness of adding dopamine agonist therapy to long-acting somatostatin analogues in the management of acromegaly
    Selvarajah, D
    Webster, J
    Ross, R
    Newell-Price, J
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2005, 152 (04) : 569 - 574
  • [27] Effectiveness of combined dopamine agonist and long-acting somatostatin analogues in the management of resistant acromegaly
    Selvarajah, D
    Webster, J
    Ross, R
    Newell-Price, J
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2005, 152
  • [28] Efficacy and Safety of Long-Acting β-Agonist/Long-Acting Muscarinic Antagonist Combinations Compare to Long-Acting β-Agonist/Inhaled Corticosteroid Combinations: A Network Meta-Analysis
    Ahmed, T. Said
    Al-Sarie, M.
    Srour, K.
    Rygielski, S.
    Ye, F.
    Hernandez, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [29] PRAMIPEXOLE - A DOPAMINE-RECEPTOR AGONIST FOR TREATMENT OF PARKINSONS-DISEASE
    MIERAU, J
    CLINICAL NEUROPHARMACOLOGY, 1995, 18 : S195 - S206
  • [30] Discovery of a Novel, Long-Acting Amylin Receptor Agonist for Body Weight Control
    Li, Yan
    Zou, Haixia
    Wu, Xinle
    Zhu, Rui
    Wang, Ruipeng
    Hao, Sujuan
    Li, Zhaoying
    Wang, Yaxu
    Deng, Jianhui
    Wang, Hongyang
    Peng, Fei
    Jones, Catherine L.
    Fenaux, Martijn
    DIABETES, 2024, 73
12345